Elephas specializes in development and research for novel cancer diagnostic solutions, treatments, and drug therapies. Elephas' primary solution is its imaging platform technology, designed to assess how live tumor fragments respond to cancer therapies, thus removing trial-and-error approaches to cancer care. Elephas' mission is to advance multimodal microscopy, and AI to accelerate drug treatments and empower clinical decision making.

Register To Buy and Sell Shares

For more details on financing and valuation for Elephas, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Elephas’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Elephas.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Elephas’ stock FAQs


Can you buy Elephas’ stock?

Elephas is not publicly traded on NYSE or NASDAQ in the U.S. To buy Elephas’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Elephas’ stock?

Yes, you can sell stock of a private company like Elephas. Forge can help you sell your Elephas stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Elephas’ stock price?

Elephas is a privately held company and therefore does not have a public stock price. However, you may access Elephas’ private market stock price with Forge Data.

What is Elephas’ stock ticker symbol?

Elephas does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Elephas Announces $41.5 Million in Series B Funding

ARCH Venture Partners led the round, and were joined by new investors, Moore Strategic Ventures and Tao Capital Partners. Continuing investments were made by Northpond Ventures, Sands Capital, and WARF Ventures. Prior investments include $20 million from the Series A and $8 million from the founder and early seed investors.
Updated on: Jun 24, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.